This article was published in Law360 on May 23, 2017. © Copyright 2017, Portfolio Media, Inc., publisher of Law360. It is republished here with permission.
The multidistrict litigation over alleged price-fixing of generic drugs recently consolidated in Pennsylvania’s Eastern District has the potential to emerge as one of the thorniest court fights in the country, and some observers have raised concerns that the numerous defendants could make it harder for individual companies to avoid getting more deeply embroiled in the litigation.
Pepper Hamilton was one of the firm’s that represented the drug companies.